Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
The Journal of Infectious Diseases|February 4, 2012
Therapeutic vaccination with recombinant adenovirus reduces splenic parasite burden in experimental visceral leishmaniasisAsher Maroof, Najmeeyah Brown, Barbara Smith, et al.
Plos Neglected Tropical Diseases|March 25, 2021
Suitability of current typing procedures to identify epidemiologically linked human Giardia duodenalis isolatesAndreas Woschke, Mirko Faber, Klaus Stark, et al.
Plos Neglected Tropical Diseases|May 13, 2017
A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KHMohamed Osman, Anoop Mistry, Ada Keding, et al.
Plos Pathogens|January 8, 2026
Arginine metabolism has a pivotal function for the encystation of Giardia duodenalisChristian Klotz, Ricarda Leisering, Kari D Hagen, et al.
Proteomics|March 29, 2002
Immunoproteomics of Helicobacter pylori infection and relation to gastric diseaseGaby Haas, Galip Karaali, Karl Ebermayer, et al.
International Journal for Parasitology. Drugs and Drug Resistance|May 26, 2018
Comment on "The optimal timing of post-treatment sampling for the assessment of anthelminthic drug efficacy against Ascaris infections in humans"Jürgen Krücken, Kira Fraundorfer, Jean Claude Mugisha, et al.
Malaria Journal|November 16, 2016
Asymptomatic only at first sight: malaria infection among schoolchildren in highland RwandaKevin C Sifft, Dominik Geus, Caritas Mukampunga, et al.
International Journal for Parasitology. Drugs and Drug Resistance|July 12, 2017
Reduced efficacy of albendazole against Ascaris lumbricoides in Rwandan schoolchildrenJürgen Krücken, Kira Fraundorfer, Jean Claude Mugisha, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 30, 2021
Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in SudanBrima M Younis, Mohamed Osman, Eltahir A G Khalil, et al.
Plos One|June 24, 2011
The IFN-γ-inducible GTPase, Irga6, protects mice against Toxoplasma gondii but not against Plasmodium berghei and some other intracellular pathogensOliver Liesenfeld, Iana Parvanova, Jens Zerrahn, et al.
Pageof 7